Study Design: Retrospective before-after comparison study.
Objective: The primary aim of this study was to evaluate the effectiveness of a radiofrequency-based bipolar hemostatic sealer during surgical correction of adolescent idiopathic scoliosis (AIS).
Summary Of Background Data: Spinal reconstructive surgery is commonly associated with excessive blood loss. Perioperative bleeding is of particular concern during correction of AIS, which often requires allogeneic or autologous transfusion. However, there are specific risks and limitations that often preclude the utilization of transfusions. Alternatives include the use of antifibrinolytic drugs and topical fibrin-based and thrombin-based agents, although safety and effectiveness are yet to be fully established. There is a clear need for assessing alternative methods of hemostasis.
Methods: One hundred seventy-six AIS patients undergoing corrective spinal surgery were included in this study. Seventy-six consecutive patients were treated intraoperatively with a standard method of hemostasis consisting of hypotensive anesthesia, thrombin-soaked sponges, and intraoperative blood salvage (Control). Subsequently, an additional 100 consecutive patients were treated after the introduction of a bipolar sealer (Aquamantys 2.3 Bipolar Sealer, Salient Surgical Technologies, Portsmouth, NH). The outcomes of this study were estimated blood loss (total and per level) and transfusion rate.
Results: Blood loss was reduced by 57% after the introduction of the bipolar sealer compared with the Control (bipolar sealer: 435±192 mL, Control: 1009±392 mL; P<0.001). There was a statistically significant difference between groups for blood loss per fusion level (bipolar sealer: 39±17 mL, Control: 95±33 mL; P<0.001). Five (6.6%) Control patients required blood transfusions versus none treated with the bipolar sealer (P=0.014). Complication rates were similar between the groups.
Conclusions: These findings suggest that the Aquamantys 2.3 bipolar sealer effectively supports hemostasis and reduces the need for transfusions during surgical correction of AIS.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/BSD.0b013e3182334ec5 | DOI Listing |
Arch Orthop Trauma Surg
January 2025
Department of Public Health, Orthopedic Unit, "Federico II" University, Naples, Italy.
Background: Two-stage revision in infected total knee arthroplasty increases the risk of blood loss and the need for transfusion. The present study aimed to test the hemostatic efficacy of a bipolar sealer to reduce blood loss and transfusion requirements after the first stage in patients affected by peri-prosthetic knee infections.
Methods: Twenty-four patients undergoing 2-stage arthroplasty for infected TKA using a bipolar sealer (Haemodiss, Kylix, Naples, IT) were compared with 24 patients of a historical control group in which conventional electrocautery was used.
Int J Surg Case Rep
November 2024
Department of Plastic Surgery, Kobe University Graduate School of Medicine, Japan.
Ann Surg Oncol
January 2025
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Arthroplast Today
October 2024
Department of Orthopaedic Surgery, Syosset Hospital, Northwell Health, Syosset, NY, USA.
Background: This was a noninferiority trial to evaluate blood loss during total knee arthroplasty (TKA) when using the unipolar electrocautery system compared to the saline coupled bipolar sealer system in primary TKA.
Methods: One hundred sixty-four patients were randomly assigned by a 1:1 ratio to either the unipolar electrocautery system (N = 82) or bipolar sealer system (N = 82). Inclusion criteria included patients scheduled for primary unilateral TKA, preoperative hemoglobin ≥11 mg/dL, preoperative platelet count ≥150,000, age >18 years, and patient willing to complete all study-related procedures.
Multimed Man Cardiothorac Surg
August 2024
Department of General Thoracic Surgery, Gifu University Hospital, Gifu, Japan.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!